Learning Objectives:

  • Understand how digital pathology can improve prediction of recurrence in HR+/HER2- breast cancer
  • Utilize clinicopathologic characteristics in combination with genomic testing to risk stratify early breast cancer
  • Describe how generative artificial intelligence techniques can be leveraged to understand treatment response
Session date: 
09/11/2023 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Frederick Howard, MD